X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1246) 1246
index medicus (1244) 1244
female (580) 580
hla-dr4 antigen - genetics (539) 539
male (529) 529
adult (393) 393
alleles (342) 342
middle aged (329) 329
hla-dr antigens - genetics (312) 312
hla-dr4 antigen (309) 309
immunology (308) 308
arthritis, rheumatoid - genetics (285) 285
arthritis, rheumatoid - immunology (282) 282
abridged index medicus (270) 270
diabetes mellitus, type 1 - genetics (220) 220
hla-dr4 (211) 211
rheumatology (205) 205
susceptibility (195) 195
adolescent (192) 192
animals (184) 184
aged (181) 181
hla-dr4 antigen - immunology (180) 180
rheumatoid arthritis (178) 178
child (173) 173
genotype (173) 173
haplotypes (172) 172
association (171) 171
diabetes mellitus, type 1 - immunology (171) 171
molecular sequence data (169) 169
hla-dq antigens - genetics (160) 160
gene frequency (155) 155
mice (154) 154
hla-drb1 chains (147) 147
hla-dr4 antigen - analysis (142) 142
genetic predisposition to disease (140) 140
antigens (135) 135
histocompatibility antigens class ii - genetics (134) 134
amino acid sequence (132) 132
t-lymphocytes - immunology (132) 132
hla antigens - genetics (131) 131
hla (128) 128
risk factors (123) 123
disease susceptibility (117) 117
phenotype (108) 108
disease (107) 107
polymorphism, genetic (105) 105
rheumatoid-arthritis (105) 105
hla-dr3 antigen - genetics (100) 100
polymerase chain reaction (99) 99
autoimmunity (98) 98
base sequence (98) 98
genes, mhc class ii (98) 98
mice, transgenic (97) 97
child, preschool (89) 89
hla-dr3 antigen (87) 87
histocompatibility testing (86) 86
major histocompatibility complex (84) 84
genes (83) 83
antibodies (80) 80
autoantibodies (80) 80
hla-dr antigens - analysis (78) 78
genetic aspects (76) 76
polymorphism, restriction fragment length (74) 74
hla-dr (73) 73
hla-dr4 antigen - metabolism (73) 73
histocompatibility antigens class ii - analysis (72) 72
hla-dr antigens - immunology (71) 71
hla-dr antigens (69) 69
endocrinology & metabolism (68) 68
hla antigens - analysis (68) 68
hla-d antigens - genetics (68) 68
cell line (67) 67
histocompatibility antigen hla (65) 65
peptides (65) 65
type 1 diabetes (64) 64
risk (63) 63
cell biology (62) 62
autoimmune diseases - immunology (61) 61
case-control studies (61) 61
medicine, general & internal (60) 60
hla histocompatibility antigens (59) 59
cd4-positive t-lymphocytes - immunology (57) 57
autoimmune diseases - genetics (56) 56
genetic markers (56) 56
histocompatibility antigens class ii - immunology (56) 56
autoantibodies - blood (55) 55
infant (55) 55
genetics (54) 54
t cells (52) 52
epitopes (51) 51
pedigree (51) 51
genetics & heredity (50) 50
polymorphism (50) 50
hla-dr4 antigen - blood (49) 49
transgenic mice (49) 49
aged, 80 and over (48) 48
arthritis (48) 48
epitopes - immunology (48) 48
analysis (46) 46
physiological aspects (46) 46
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1233) 1233
French (17) 17
Chinese (15) 15
German (12) 12
Japanese (10) 10
Russian (6) 6
Spanish (6) 6
Polish (3) 3
Italian (2) 2
Norwegian (2) 2
Hungarian (1) 1
Portuguese (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 07/2014, Volume 371, Issue 1, pp. 42 - 49
In this cohort study involving 6403 children at increased risk for celiac disease on the basis of HLA haplotype, the risks of celiac disease autoimmunity and... 
ANTIBODIES | MEDICINE, GENERAL & INTERNAL | GLUTEN | AUTOIMMUNITY | GENE DOSAGE | SUSCEPTIBILITY | TEDDY | CHILDHOOD | CHILDREN | Autoimmune Diseases - epidemiology | United States - epidemiology | Genetic Predisposition to Disease | Prospective Studies | Celiac Disease - genetics | Humans | Kaplan-Meier Estimate | Child, Preschool | Europe - epidemiology | Infant | Male | Risk | Transglutaminases - immunology | Autoimmune Diseases - genetics | Homozygote | HLA-DR4 Antigen - genetics | HLA-DR3 Antigen - genetics | HLA-DQ Antigens - genetics | Antibodies - blood | Female | Celiac Disease - epidemiology | Infant, Newborn | Haplotypes | Viral antibodies | Celiac disease | Histocompatibility antigens | Analysis | HLA histocompatibility antigens | Antibodies | Children | Health aspects | Risk factors | Diabetes mellitus | Heterozygotes | Environmental factors | Small intestine | Transglutaminase 2 | Children & youth | Homozygotes | Genotype & phenotype | Biopsy | Histocompatibility antigen HLA | Autoimmune diseases | Age | Genotypes | Immune system | Index Medicus | Abridged Index Medicus | Autoimmune Diseases: epidemiology | Celiac Disease: genetics | Medical and Health Sciences | Medicin och hälsovetenskap | Europe: epidemiology | Antibodies: blood | HLA-DQ Antigens: genetics | HLA-DR3 Antigen: genetics | Klinisk medicin | Transglutaminases: immunology | United States: epidemiology | HLA-DR4 Antigen: genetics | Clinical Medicine | Endokrinologi och diabetes | Autoimmune Diseases: genetics | Celiac Disease: epidemiology | Endocrinology and Diabetes
Journal Article
Nature Immunology, ISSN 1529-2908, 10/2015, Volume 16, Issue 11, pp. 1153 - 1161
Journal Article
Journal of Experimental Medicine, ISSN 0022-1007, 11/2013, Volume 210, Issue 12, pp. 2569 - 2582
Journal Article
Clinical & Experimental Immunology, ISSN 0009-9104, 12/2015, Volume 182, Issue 3, pp. 251 - 260
Peptide immunotherapy (PIT) is a targeted therapeutic approach, involving administration of disease‐associated peptides, with the aim of restoring... 
regulatory T cells | autoimmunity | antigens/peptides/epitopes | T cells | diabetes | Autoimmunity | Antigens peptides epitopes | Diabetes | Regulatory T cells | NOD MICE | DENDRITIC CELLS | TOLERANCE | peptides | AUTOANTIGEN | INDUCTION | INTERLEUKIN-10 | IMMUNOLOGY | antigens | INSULIN | epitopes | RESPONSES | EXPRESSION | Humans | Diabetes Mellitus, Experimental - genetics | Diabetes Mellitus, Type 1 - therapy | Diabetes Mellitus, Experimental - therapy | T-Lymphocytes, Regulatory - pathology | T-Lymphocytes, Regulatory - immunology | Immunotherapy | Diabetes Mellitus, Type 1 - immunology | Interferon-gamma - genetics | Proinsulin - pharmacology | Cell Proliferation - genetics | HLA-DRB1 Chains - genetics | HLA-DRB1 Chains - immunology | Diabetes Mellitus, Type 1 - pathology | Diabetes Mellitus, Type 1 - genetics | Mice, Transgenic | Peptides - pharmacology | Diabetes Mellitus, Experimental - immunology | Autoantibodies - immunology | HLA-DR4 Antigen - genetics | Animals | Interferon-gamma - immunology | Interleukin-10 - genetics | Diabetes Mellitus, Experimental - pathology | Cell Proliferation - drug effects | Mice | Interleukin-10 - immunology | HLA-DR4 Antigen - immunology | Histocompatibility antigens | Peptides | Analysis | HLA histocompatibility antigens | Genetic engineering | Antigens | Lymphocytes | Rodents | Autoimmune diseases | Index Medicus | Original
Journal Article
Infection and Immunity, ISSN 0019-9567, 11/2018, Volume 86, Issue 11
Journal Article
Journal Article
Journal Article
Clinical & Experimental Immunology, ISSN 0009-9104, 11/2016, Volume 186, Issue 2, pp. 164 - 176
Journal Article
PLoS ONE, ISSN 1932-6203, 12/2013, Volume 8, Issue 12, pp. e84908 - e84908
Reports have shown that activation of tumor-specific CD4(+) helper T (Th) cells is crucial for effective anti-tumor immunity and identification of Th-cell... 
SURVIVAL | IMMUNITY | COMPLEX | MELANOMA | HELPER | PEPTIDES | DENDRITIC CELLS | MEMORY | MULTIDISCIPLINARY SCIENCES | VACCINATION | GENERATION | Antigens, Neoplasm - genetics | Antigens, Neoplasm - immunology | Cancer Vaccines - pharmacology | Humans | Peptides - immunology | Neoplasm Proteins - immunology | Peptides - genetics | Epitopes, T-Lymphocyte - genetics | Mice, Transgenic | Cancer Vaccines - genetics | Cancer Vaccines - immunology | HLA-DR4 Antigen - genetics | Animals | Urinary Bladder Neoplasms - genetics | T-Lymphocytes, Helper-Inducer - immunology | Urinary Bladder Neoplasms - therapy | Urinary Bladder Neoplasms - immunology | Mice | Epitopes, T-Lymphocyte - immunology | Neoplasm Proteins - genetics | HLA-DR4 Antigen - immunology | Peptides | Vaccination | Helper cells | Bladder | Cytotoxicity | Identification | Lymphocytes T | Vaccines | Immunity | Population genetics | Urology | Anticancer properties | Proteins | Cancer vaccines | Cell activation | Urinary bladder | Lymphocytes | Transgenic animals | Rodents | Immunotherapy | Bone marrow | Drb1 protein | Binding | Antigens | Immunization | Dendritic cells | Transgenic mice | Melanoma | Amino acid sequence | L cells | Epitopes | Wilms' tumor | Gene expression | Bladder cancer | CD4 antigen | Algorithms | Acids | Antigen (tumor-associated) | Pancreatic cancer | Histocompatibility antigen HLA | Human behavior | Cancer | Index Medicus
Journal Article